Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany.
Dermatol Ther. 2010 Nov-Dec;23(6):567-80. doi: 10.1111/j.1529-8019.2010.01364.x.
Cutaneous metastases of internal malignancies still seem to occur infrequently, although medical publications report an incidence rate of up to 10.4%. Common sense, however, fosters suspicion that we might underdiagnose the problem distracted by harder striking facets of an advanced disease. With contemporary knowledge, morphology and behavior of cutaneous metastases resemble each other regardless of the site of origin. This article itemizes clinical presentations according to organ systems, specific features, and differential diagnoses. In general, the survival turned out to be less than 12 months. But incremental awareness of cutaneous metastases proclaims this paradigm insufficient. Although excision is the local treatment of choice, investigations attempt to propose tumor-specific chemotherapeutic/immunological approaches. This paper endeavors to critically review the state of the art concerning the clinic, prognosis, and therapeutic concepts.
皮肤转移瘤虽然在医学文献中的发生率高达 10.4%,但似乎仍不常见。然而,常识使我们怀疑,由于我们可能会被晚期疾病中更明显的特征分散注意力,从而导致对该问题的诊断不足。根据目前的知识,无论起源部位如何,皮肤转移瘤的形态和行为都相似。本文根据器官系统、特征和鉴别诊断对临床表现进行了分类。一般来说,患者的生存时间不到 12 个月。但对皮肤转移瘤的认识不断提高,宣告了这一模式的不足。虽然切除是局部治疗的首选,但研究试图提出针对肿瘤的化疗/免疫治疗方法。本文旨在批判性地回顾有关临床、预后和治疗概念的最新进展。